The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1270 articles
In a significant victory for healthcare cost containment, the Supreme Court has allowed Medicare to proceed with negotiating drug prices. This decision upholds a key provision of the Inflation Reduction Act and could impact the cost of many prescription medications, including widely used GLP-1 agonists.
A new controlled study suggests that swapping processed snacks for a daily serving of almonds can enhance gut bacteria, lower inflammation, and increase satiety hormones like GLP-1.
Peptide therapy is gaining traction, with compounds like semaglutide revolutionizing weight management. But what exactly are peptides, and what are the realities behind the trending 'peptide summer'? This article delves into the science, the risks, and the future of this evolving field.
Looksmaxxing, a trend focused on extreme self-improvement and physical optimization, has gained significant traction online. While some aspects involve standard grooming and fitness, others venture into dangerous territory, including bone-smashing and unregulated injectable substances. This article delves into the spectrum of looksmaxxing, its psychological underpinnings, and the serious health risks associated with its more extreme practices.
A groundbreaking study reveals that the Mediterranean diet may boost cellular health by activating specific mitochondrial microproteins, offering a new perspective on its profound anti-aging benefits.
Tired of constant cravings derailing your health goals? A UK surgeon reveals a simple yet effective 6-step strategy to boost satiety and minimize hunger throughout the day. Learn how to leverage the power of fiber, hydration, and smart eating habits for lasting fullness.
Peptides offer targeted health benefits, from weight loss to injury healing, but safety varies significantly. Explore the science, risks, and medical guidance required.
Peptides are powerful signaling molecules, but they are not a universal cure-all. This deep dive clarifies the function of GLP-1 agonists, cosmetic peptides, and the critical importance of medical guidance when considering peptide therapies for weight management or anti-aging.
The race for dominance in the lucrative weight loss drug market is intensifying. While Novo Nordisk's Wegovy has been a pioneer, Eli Lilly is rapidly advancing its pipeline with next-generation therapies poised to challenge the status quo. This article delves into the science, clinical data, and market implications of these groundbreaking treatments.
